期刊文献+

miR-150和miR-134在结直肠癌及腺瘤中的表达 被引量:4

Expression of miR-150 and miR-134 in colorectal cancer and colorectal adenoma
原文传递
导出
摘要 目的:探讨miR-150和miR-134在结直肠癌与结直肠腺瘤中的表达及意义。方法:采用实时定量荧光PCR(qRT-PCR)检测40例结直肠癌组织及其癌旁正常组织与29例结直肠腺瘤组织中miR-150和miR-134表达,并分析两者与结直肠癌临床病理因素之间的关系。结果:与癌旁正常组织比较,miR-150在腺瘤组织中表达明显升高,而在癌组织中表达明显降低(均P<0.05);miR-134在腺瘤组织中表达明显降低(P<0.05),但在癌组织中表达差异无统计学意义(P>0.05);miR-150表达水平与结直肠癌的组织学类型及分化程度有关(P=0.033,P=0.041);miR-134表达水平与结直肠癌的各项临床病理因素均无明显关系(均P>0.05)。结论:miR-150在结直肠癌中表达下调,提示其可能有潜在的抑癌作用,miR-150和miR-134在结直肠腺瘤中的表达均发生异常,提示两者均可能与结直肠腺瘤的发生密切相关。 Objective: To investigate the expression of miR-150 and miR-134 in colorectal cancer and colorectal adenoma and evaluate the significance. Methods: The miR-150 and miR-134 expressions in 40 tissue specimens of colorectal cancer along with their adjacent normal mucosa and 29 tissue specimens of colorectal adenoma were determined by real-time quantitative reverse transcription-PCR (qRT-PCR) Results: Compared with normal mucosal tissue, the miR-150 expression was significantly adenoma, while was significantly decreased in colorectal cancer (both P〈0.05); the increased in colorectal miR- 134 expression was significantly decreased in colorectal adenoma (P〈0.05), but showed no obvious difference in colorectal cancer (P〉0.05). The miR-150 expression level was significantly related to the histological type and degree ofdifferentiation of colorectal cancer (P=0.033, P=0.041), while the miR-150 expression level was irrelevant to any of the clinicopathologic factors ofcolorectal cancer (all P〉0.05). Conclusion: milk-150 expression is down-regulated in colorectal cancer, suggesting that miR-150 may probably have a potential anti-tumor activity; both miR-150 and miR-134 expression are abnormal in colorectal adenoma, suggesting that they may be closely related to the occurrence of colorectal adenoma.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2014年第10期1349-1354,共6页 China Journal of General Surgery
基金 国家自然科学基金资助项目(81072034) 河北省自然科学研究计划资助项目(C2011206103) 河北省国际合作资助项目(12396105D)
关键词 结直肠肿瘤 腺瘤 微RNAS Colorectal Neoplasms Carcinoma Adenoma MicroRNAs
  • 相关文献

参考文献4

二级参考文献41

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献998

同被引文献22

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部